Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016-2022)
- PMID: 40602701
- DOI: 10.1016/j.autrev.2025.103863
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016-2022)
Abstract
Background: ANCA-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA), is a systemic autoimmune disease. This study represents the first large-scale analysis of AAV hospitalisation rates and in-hospital mortality trends in Spain.
Methods: A retrospective longitudinal analysis of AAV-related hospital admissions between 2016 and 2022 was conducted using the ICD-10 codes from the Minimum Basic Dataset (MBDS) of the Spanish National Health System. Statistical analyses were performed, including odds ratios, Student's t-tests, and Mantel-Haenszel trend tests.
Results: Among 5753 AAV episodes, GPA was the most frequent subtype (53.9 %), followed by MPA (31.5 %) and EGPA (14.6 %). AAV episodes were more frequent in older patients (> 65 years) than in other hospital episodes (62.9 % vs. 38.9 %; OR: 2.66, 95 %CI: 2.51-2.80; P < 0.001). Larger hospitals accounted for more AAV episodes, longer hospital stays, and higher costs. MPA had the highest mortality rate (7.2 % vs. 4.9 %; OR: 1.52, 95 % CI: 1.27-1.79; P < 0.001), particularly in patients over 65 years (83.1 % vs. 61.8 %; OR: 3.04, 95 % CI: 2.47-3.75; P < 0.001) compared with the other AAV. In the GPA group, renal involvement significantly increased mortality compared to GPA cases without renal involvement (6.6 % vs. 4.6 %; OR: 1.46, 95 % CI: 1.16-1.83; P = 0.011). Notably, the relative risk of AAV-related deaths increased over the study period (Z = 2.77, P < 0.01).
Conclusion: AAV, particularly MPA, is associated with increased hospital mortality, particularly among older adults and patients with renal involvement.
Keywords: ANCA-associated vasculitis; Eosinophilic granulomatosis with polyangiitis; Epidemiology; Granulomatosis with polyangiitis; Microscopic polyangiitis; Mortality.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no conflicts of interest, including any financial, personal, or other relationships within three years of beginning this research, with a person or organisation that could have inappropriately influenced or be perceived to influence this work.
Similar articles
-
Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: a systematic review and meta-analysis.Arthritis Res Ther. 2021 Jan 14;23(1):28. doi: 10.1186/s13075-021-02415-z. Arthritis Res Ther. 2021. PMID: 33446268 Free PMC article.
-
The role of tobacco smoking in anti-neutrophil cytoplasmic antibody-associated vasculitis: a systematic review.Clin Exp Rheumatol. 2024 Jul;42(7):1321-1332. doi: 10.55563/clinexprheumatol/nu8ngr. Epub 2024 Jul 4. Clin Exp Rheumatol. 2024. PMID: 38976289
-
Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.J Intern Med. 2024 May;295(5):651-667. doi: 10.1111/joim.13777. Epub 2024 Mar 11. J Intern Med. 2024. PMID: 38462959
-
Incidence and prevalence of ANCA-associated vasculitis in Oslo, Norway, applying different criteria-based case definitions: a population-based cohort study.RMD Open. 2025 Jul 5;11(3):e005526. doi: 10.1136/rmdopen-2025-005526. RMD Open. 2025. PMID: 40617587 Free PMC article.
-
Clinical Burden and Costs of Anti-Neutrophil Cytoplasmic Antibody-ANCA-Associated Vasculitis: Main Findings from REDCap Registry of a University Hospital in Spain.Clinicoecon Outcomes Res. 2025 Aug 1;17:537-546. doi: 10.2147/CEOR.S529853. eCollection 2025. Clinicoecon Outcomes Res. 2025. PMID: 40766903 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources